1. Narimani, Manizheh, Sharifi, Mohammadreza, Hakhamaneshi, Mohammad Saeed, Hejazi, Seyed Hossein, Jalili, Ali. 2019. BIRC5 Gene Disruption via CRISPR/Cas9n Platform Suppress Acute Myelocytic Leukemia Progression. In Iranian biomedical journal, 23, 369-78. doi:. https://pubmed.ncbi.nlm.nih.gov/31104397/
2. Zhuang, Jia, Gong, Hua, Zhou, Jiarong, Fang, Ronnie H, Zhang, Liangfang. 2020. Targeted gene silencing in vivo by platelet membrane-coated metal-organic framework nanoparticles. In Science advances, 6, eaaz6108. doi:10.1126/sciadv.aaz6108. https://pubmed.ncbi.nlm.nih.gov/32258408/
3. Jiang, Xiulin, Shi, Yulin, Chen, Xi, Li, Lihua, Pu, Jun. 2022. The N6-Methylandenosine-Related Gene BIRC5 as a Prognostic Biomarker Correlated With Cell Migration and Immune Cell Infiltrates in Low Grade Glioma. In Frontiers in molecular biosciences, 9, 773662. doi:10.3389/fmolb.2022.773662. https://pubmed.ncbi.nlm.nih.gov/35309512/
4. Hattori, Etsuko Yamamoto, Masuda, Tatsuya, Mineharu, Yohei, Arakawa, Yoshiki, Kamikubo, Yasuhiko. 2022. A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice. In Communications biology, 5, 939. doi:10.1038/s42003-022-03917-5. https://pubmed.ncbi.nlm.nih.gov/36085167/
5. Narimani, Manizheh, Sharifi, Mohammadreza, Jalili, Ali. 2019. Knockout Of BIRC5 Gene By CRISPR/Cas9 Induces Apoptosis And Inhibits Cell Proliferation In Leukemic Cell Lines, HL60 And KG1. In Blood and lymphatic cancer : targets and therapy, 9, 53-61. doi:10.2147/BLCTT.S230383. https://pubmed.ncbi.nlm.nih.gov/31819702/
6. Xu, Ming, Hu, Xianyu, Zhang, Meng, Ge, Yating. 2019. What is the impact of BIRC5 gene polymorphisms on urinary cancer susceptibility? Evidence from 9348 subjects. In Gene, 733, 144268. doi:10.1016/j.gene.2019.144268. https://pubmed.ncbi.nlm.nih.gov/31809840/
7. Aslan, Elif Sibel, Yavas, Cuneyd, Akcali, Nermin, Meral, Gulsen, Batur, Lutfiye Karcioglu. 2025. The functional correlation between mir-16-5p and BIRC5 gene in colorectal cancer: integrated analysis of transcriptomics and in vitro validation. In Molecular biology reports, 52, 252. doi:10.1007/s11033-025-10355-z. https://pubmed.ncbi.nlm.nih.gov/39976834/
8. Fäldt Beding, Anna, Larsson, Peter, Helou, Khalil, Einbeigi, Zakaria, Parris, Toshima Z. 2022. Pan-cancer analysis identifies BIRC5 as a prognostic biomarker. In BMC cancer, 22, 322. doi:10.1186/s12885-022-09371-0. https://pubmed.ncbi.nlm.nih.gov/35331169/
智鼠故事 
